$PPCH-Propanc's new cancer drug was based on the original work undertaken nearly 100 years ago, using fresh pancreatic enzyme extracts. Through advancements in science and technology, company has discovered an opportunity to commercialise an improved version of this drug administered once daily in an outpatient setting. intention is to supply this treatment to markets worldwide
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.